Curcumin Attenuates Gentamicin-Induced Kidney Mitochondrial Alterations: Possible Role of a Mitochondrial Biogenesis Mechanism

Evidence-based Complementary and Alternative Medicine

Volumn 2015, Issue , 2015, Pages

  Negrette Guzmán, Mario ^a   García Niño, Wylly Ramsés ^b   Tapia, Edilia ^b   Zazueta, Cecilia ^b   Huerta Yepez, Sara ^c   León Contreras, Juan Carlos ^d   Hernández Pando, Rogelio ^d   Aparicio Trejo, Omar Emiliano ^a   Madero, Magdalena ^b   Pedraza Chaverri, José ^a  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^b INSTITUTO NACIONAL DE CARDIOLOGÍA IGNACIO CHÁVEZ   (Mexico)

^c HOSPITAL INFANTIL DE MÉXICO FEDERICO GÓMEZ   (Mexico)

^d INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

CURCUMIN; GENTAMICIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; TRANSCRIPTION FACTOR NRF2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOGENESIS; CELL ULTRASTRUCTURE; CELL VIABILITY; CONTROLLED STUDY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; IN VIVO STUDY; KIDNEY DISEASE; MALE; NEPHROTOXICITY; NONHUMAN; PERMEABILITY; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; RAT;

EID: 84939641303     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2015/917435     Document Type: Article

References (58)

1. J. Trujillo, Y. I. Chirino, E. Molina-Jijón, A. C. Andérica-Romero, E. Tapia, and J. Pedraza-Chaverrí, "Renoprotective effect of the antioxidant curcumin: recent findings," Redox Biology, vol. 1, no. 1, pp. 448-456, 2013.
2. M. Singh and N. Singh, "Molecular mechanism of curcumin induced cytotoxicity in human cervical carcinoma cells," Molecular and Cellular Biochemistry, vol. 325, no. 1-2, pp. 107-119, 2009.
3. J.-M. Kim, E.-M. Noh, K.-B. Kwon et al., "Curcumin suppresses the TPA-induced invasion through inhibition of PKCα-dependent MMP-expression in MCF-7 human breast cancer cells," Phytomedicine, vol. 19, no. 12, pp. 1085-1092, 2012.
4. H. Nishikawa, J. Tsutsumi, and S. Kitani, "Anti-inflammatory and anti-oxidative effect of curcumin in connective tissue type mast cell," Journal of Functional Foods, vol. 5, no. 2, pp. 763-772, 2013.
5. S. Z. Moghadamtousi, H. Abdul Kadir, P. Hassandarvish, H. Tajik, S. Abubakar, and K. Zandi, "A review on antibacterial, antiviral, and antifungal activity of curcumin," BioMed Research International, vol. 2014, Article ID 186864, 12 pages, 2014.
6. S.-K. Shin, T.-Y. Ha, R. A. McGregor, and M.-S. Choi, "Longterm curcumin administration protects against atherosclerosis via hepatic regulation of lipoprotein cholesterol metabolism," Molecular Nutrition and Food Research, vol. 55, no. 12, pp. 1829-1840, 2011.
7. M. R. Smith, S. R. Gangireddy, V. R. Narala et al., "Curcumin inhibits fibrosis-related effects in IPF fibroblasts and in mice following bleomycin-induced lung injury," The American Journal of Physiology-Lung Cellular andMolecular Physiology, vol. 298, no. 5, pp. L616-L625, 2010.
8. S. González-Reyes, S. Guzmán-Beltrán, O. N. Medina-Campos, and J. Pedraza-Chaverri, "Curcumin pretreatment inducesNrf2 and an antioxidant response and prevents hemin-induced toxicity in primary cultures of cerebellar granule neurons of rats," Oxidative Medicine and Cellular Longevity, vol. 2013, Article ID 801418, 14 pages, 2013.
9. W. R. García-Niño and J. Pedraza-Chaverrí, "Protective effect of curcumin against heavy metals-induced liver damage," Food and Chemical Toxicology, vol. 69, pp. 182-201, 2014.
10. J. Trujillo, L. F. Granados-Castro, C. Zazueta, A. C. Andérica-Romero, Y. I. Chirino, and J. Pedraza-Chaverrí, "Mitochondria as a target in the therapeutic properties of curcumin," Archiv der Pharmazie, vol. 347, no. 12, pp. 873-884, 2014.
11. A. González-Salazar, E. Molina-Jijón, F. Correa et al., "Curcumin protects fromcardiac reperfusion damage by attenuation of oxidant stress and mitochondrial dysfunction," Cardiovascular Toxicology, vol. 11, no. 4, pp. 357-364, 2011.
12. F. Correa, M. Buelna-Chontal, S. Hernández-Reséndiz et al., "Curcumin maintains cardiac and mitochondrial function in chronic kidney disease," Free Radical Biology andMedicine, vol. 61, pp. 119-129, 2013.
13. M. Izem-Meziane, B. Djerdjouri, S. Rimbaud et al., "Catecholamine-induced cardiac mitochondrial dysfunction and mPTP opening: protective effect of curcumin," The American Journal of Physiology-Heart and Circulatory Physiology, vol. 302, no. 3, pp. H665-H674, 2012.
14. P. H. Xu, Y. L. Yao, P. J. Guo, T. Wang, B.W. Yang, and Z. Zhang, "Curcumin protects rat heart mitochondria against anoxiareoxygenation induced oxidative injury," Canadian Journal of Physiology and Pharmacology, vol. 91, no. 9, pp. 715-723, 2013.
15. E. Molina-Jijón, E. Tapia, C. Zazueta et al., "Curcumin prevents Cr(VI)-induced renal oxidant damage by a mitochondrial pathway," Free Radical Biology and Medicine, vol. 51, no. 8, pp. 1543-1557, 2011.
16. W. R. García-Niño, E. Tapia, C. Zazueta et al., "Curcumin pretreatment prevents potassium dichromate-induced hepatotoxicity, oxidative stress, decreased respiratory Complex i activity, and membrane permeability transition pore opening," Evidence-Based Complementary and Alternative Medicine, vol. 2013, Article ID 424692, 19 pages, 2013.
17. N. Sivalingam, J. Basivireddy, K. A. Balasubramanian, and M. Jacob, "Curcumin attenuates indomethacin-induced oxidative stress and mitochondrial dysfunction," Archives of Toxicology, vol. 82, no. 7, pp. 471-481, 2008.
18. J.-J. Kuo, H.-H. Chang, T.-H. Tsai, and T.-Y. Lee, "Positive effect of curcumin on inflammation and mitochondrial dysfunction in obese mice with liver steatosis," International Journal of Molecular Medicine, vol. 30, no. 3, pp. 673-679, 2012.
19. L. Liu, W. Zhang, L. Wang et al., "Curcumin prevents cerebral ischemia reperfusion injury via increase of mitochondrial biogenesis," Neurochemical Research, vol. 39, no. 7, pp. 1322-1331, 2014.
20. B. H. Ali, N. Al-Wabel, O. Mahmoud, H. M. Mousa, and M. Hashad, "Curcumin has a palliative action on gentamicininduced nephrotoxicity in rats," Fundamental and Clinical Pharmacology, vol. 19, no. 4, pp. 473-477, 2005.
21. E. O. Farombi and M. Ekor, "Curcumin attenuates gentamicininduced renal oxidative damage in rats," Food and Chemical Toxicology, vol. 44, no. 9, pp. 1443-1448, 2006.
22. Y. Quiros, L. Vicente-Vicente, A. I. Morales, J. M. López-Novoa, and F. J. López-Hernández, "An integrative overview on the mechanisms underlying the renal tubular cytotoxicity of gentamicin," Toxicological Sciences, vol. 119, no. 2, pp. 245-256, 2011.
23. M. Negrette-Guzmán, S. Huerta-Yepez, O. N. Medina-Campos et al., "Sulforaphane attenuates gentamicin-induced nephrotoxicity: role of mitochondrial protection," Evidence-Based Complementary and Alternative Medicine, vol. 2013, Article ID 135314, 17 pages, 2013.
24. H. Servais, P. Van Der Smissen, G. Thirion et al., "Gentamicininduced apoptosis in LLC-PK1 cells: involvement of lysosomes and mitochondria," Toxicology and Applied Pharmacology, vol. 206, no. 3, pp. 321-333, 2005.
25. A. I. Morales, D. Detaille, M. Prieto et al., "Metformin prevents experimental gentamicin-induced nephropathy by a mitochondria-dependent pathway," Kidney International, vol. 77, no. 10, pp. 861-869, 2010.
26. J. Chen, H. S. Wong, H.Y. Leung et al., "Anursolic acid-enriched extract of Cynomorium songaricum protects against carbon tetrachloride hepatotoxicity and gentamicin nephrotoxicity in rats possibly through a mitochondrial pathway: a comparison with ursolic acid," Journal of Functional Foods, vol. 7, no. 1, pp. 330-341, 2014.
27. R. Manikandan, M. Beulaja, R. Thiagarajan, A. Priyadarsini, R. Saravanan, and M. Arumugam, "Ameliorative effects of curcumin against renal injuries mediated by inducible nitric oxide synthase and nuclear factor kappa B during gentamicininduced toxicity in Wistar rats," European Journal of Pharmacology, vol. 670, no. 2-3, pp. 578-585, 2011.
28. M. Negrette-Guzmán, S. Huerta-Yepez, E. Tapia, and J. Pedraza-Chaverri, "Modulation of mitochondrial functions by the indirect antioxidant sulforaphane: a seemingly contradictory dual role and an integrative hypothesis," Free Radical Biology and Medicine, vol. 65, pp. 1078-1089, 2013.
29. R. C. Scarpulla, "Transcriptional paradigms in mammalian mitochondrial biogenesis and function," Physiological Reviews, vol. 88, no. 2, pp. 611-638, 2008.
30. H. Servais, Y. Jossin, F. Van Bambeke, P. M. Tulkens, and M.-P. Mingeot-Leclercq, "Gentamicin causes apoptosis at low concentrations in renal LLC-PK 1 cells subjected to electroporation," Antimicrobial Agents and Chemotherapy, vol. 50, no. 4, pp. 1213-1221, 2006.
31. P. D. Maldonado, D. Barrera, I. Rivero et al., "Antioxidant Sallylcysteine prevents gentamicin-induced oxidative stress and renal damage," Free Radical Biology andMedicine, vol. 35, no. 3, pp. 317-324, 2003.
32. E. Martínez-Abundis, N. García, F. Correa, S. Hernández-Reséndiz, J. Pedraza-Chaverri, and C. Zazueta, "Effects of α-mangostin on mitochondrial energetic metabolism," Mitochondrion, vol. 10, no. 2, pp. 151-157, 2010.
33. E. Balogun, M. Hoque, P. Gong et al., "Curcumin activates the haem oxygenase-1 gene via regulation of Nrf2 and the antioxidant-responsive element," Biochemical Journal, vol. 371, no. 3, pp. 887-895, 2003.
34. C. A. Piantadosi, M. S. Carraway, A. Babiker, andH. B. Suliman, "Heme oxygenase-1 regulates cardiac mitochondrial biogenesis via nrf2-mediated transcriptional control of nuclear respiratory factor-1," Circulation Research, vol. 103, no. 11, pp. 1232-1240, 2008.
35. N. C. MacGarvey, H. B. Suliman, R. R. Bartz et al., "Activation of mitochondrial biogenesis by heme oxygenase-1-mediated NFE2-related factor-2 induction rescues mice from lethal Staphylococcus aureus sepsis,"The American Journal of Respiratory and Critical Care Medicine, vol. 185, no. 8, pp. 851-861, 2012.
36. J. Palomino and J. Pachón, "Aminoglucósidos," Enfermedades Infecciosas y Microbiología Clínica, vol. 21, no. 2, pp. 105-115, 2003.
37. J. Feng, T. Tao, W. Yan, C. S. Chen, and X. Qin, "Curcumin inhibits mitochondrial injury and apoptosis fromthe early stage in EAE mice," Oxidative Medicine and Cellular Longevity, vol. 2014, Article ID728751, 10 pages, 2014.
38. A. M. Sanli, E. Turkoglu, G. Serbes et al., "Effect of curcumin on lipid peroxidation, early ultrastructural findings and neurological recovery after experimental spinal cord contusion injury in rats," Turkish Neurosurgery, vol. 22, no. 2, pp. 189-195, 2012.
39. P. Srivastava, R. S. Yadav, L. P. Chandravanshi et al., "Unraveling the mechanism of neuroprotection of curcumin in arsenic induced cholinergic dysfunctions in rats," Toxicology and Applied Pharmacology, vol. 279, no. 3, pp. 428-440, 2014.
40. J. Pan, H. Li, J.-F. Ma et al., "Curcumin inhibition of JNKs prevents dopaminergic neuronal loss in a mouse model of Parkinson's disease through suppressing mitochondria dysfunction," Translational Neurodegeneration, vol. 1, article 16, 2012.
41. M. Abdul-Hamid and N. Moustafa, "Protective effect of curcumin on histopathology and ultrastructure of pancreas in the alloxan treated rats for induction of diabetes," The Journal of Basic & Applied Zoology, vol. 66, no. 4, pp. 169-179, 2013.
42. J.-J. Kuo, H.-H. Chang, T.-H. Tsai, and T.-Y. Lee, "Curcumin ameliorates mitochondrial dysfunction associated with inhibition of gluconeogenesis in free fatty acid-mediated hepatic lipoapoptosis," International Journal ofMolecularMedicine, vol. 30, no. 3, pp. 643-649, 2012.
43. L. Gibellini, E. Bianchini, S. De Biasi, M. Nasi, A. Cossarizza, and M. Pinti, "527209," Evidence-Based Complementary and AlternativeMedicine, vol. 2015, Article ID527209, 13pages, 2015.
44. M. D. Brand and D. G. Nicholls, "Assessing mitochondrial dysfunction in cells," Biochemical Journal, vol. 435, no. 2, pp. 297-312, 2011.
45. C. F. Simmons Jr., R. T. Bogusky, and H. D. Humes, "Inhibitory effects of gentamicin on renal mitochondrial oxidative phosphorylation," The Journal of Pharmacology and Experimental Therapeutics, vol. 214, no. 3, pp. 709-715, 1980.
46. J. M. Weinberg and H. D. Humes, "Mechanisms of gentamicin induced dysfunction of renal cortical mitochondria. I. Effects of mitochondrial respiration," Archives of Biochemistry and Biophysics, vol. 205, no. 1, pp. 222-231, 1980.
47. J.M. Weinberg, P. G. Harding, and H. D. Humes, "Mechanisms of gentamicin-induced dysfunction of renal cortical mitochondria. II. Effects on mitochondrialmonovalent cation transport," Archives of Biochemistry and Biophysics, vol. 205, no. 1, pp. 232-239, 1980.
48. H. Raza, A. John, E. M. Brown, S. Benedict, and A. Kambal, "Alterations in mitochondrial respiratory functions, redox metabolism and apoptosis by oxidant 4-hydroxynonenal and antioxidants curcumin andmelatonin in PC12 cells," Toxicology and Applied Pharmacology, vol. 226, no. 2, pp. 161-168, 2008.
49. B.D. Sahu, S. Tatireddy, M. Koneru et al., "Naringin ameliorates gentamicin-induced nephrotoxicity and associated mitochondrial dysfunction, apoptosis and inflammation in rats: possible mechanism of nephroprotection," Toxicology and Applied Pharmacology, vol. 277, no. 1, pp. 8-20, 2014.
50. L. M. Mela-Riker, L. L. Widener, D. C. Houghton, and W. M. Bennett, "Renal mitochondrial integrity during continuous gentamicin treatment," Biochemical Pharmacology, vol. 35, no. 6, pp. 979-984, 1986.
51. C.-L. Yang, X.-H. Du, and Y.-X. Han, "Renal cortical mitochondria are the source of oxygen free radicals enhanced by gentamicin," Renal Failure, vol. 17, no. 1, pp. 21-26, 1995.
52. C. E. Guerrero-Beltrán, M. Calderón-Oliver, E. Martínez-Abundis et al., "Protective effect of sulforaphane against cisplatin-induced mitochondrial alterations and impairment in the activity of NAD(P)H: quinone oxidoreductase 1 and γglutamyl cysteine ligase: studies in mitochondria isolated from rat kidney and in LLC-PK1 cells," Toxicology Letters, vol. 199, no. 1, pp. 80-92, 2010.
53. A. P. Halestrap, G. P. McStay, and S. J. Clarke, "The permeability transition pore complex: another view," Biochimie, vol. 84, no. 2-3, pp. 153-166, 2002.
54. M. Crompton, "Themitochondrial permeability transition pore and its role in cell death," The Biochemical Journal, vol. 341, part 2, pp. 233-249, 1999.
55. S. Orrenius, "Reactive oxygen species in mitochondriamediated cell death," DrugMetabolism Reviews, vol. 39, no. 2-3, pp. 443-455, 2007.
56. A. Rasola and P. Bernardi, "Mitochondrial permeability transition in Ca2+-dependent apoptosis and necrosis," Cell Calcium, vol. 50, no. 3, pp. 222-233, 2011.
57. N. Dehne, U. Rauen, H. De Groot, and J. Lautermann, "Involvement of the mitochondrial permeability transition in gentamicin ototoxicity," Hearing Research, vol. 169, no. 1-2, pp. 47-55, 2002.
58. A. Muthuraman, S. K. Singla, A. Rana, A. Singh, and S. Sood, "Reno-protective role of flunarizine (mitochondrial permeability transition pore inactivator) against gentamicin induced nephrotoxicity in rats," Journal of the Pharmaceutical Society of Japan, vol. 131, no. 3, pp. 437-443, 2011.